220 related articles for article (PubMed ID: 26316385)
1. Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
Lanternier F; Poiree S; Elie C; Garcia-Hermoso D; Bakouboula P; Sitbon K; Herbrecht R; Wolff M; Ribaud P; Lortholary O;
J Antimicrob Chemother; 2015 Nov; 70(11):3116-23. PubMed ID: 26316385
[TBL] [Abstract][Full Text] [Related]
2. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Salmanton-García J; Seidel D; Koehler P; Mellinghoff SC; Herbrecht R; Klimko N; Ráčil Z; Falces-Romero I; Ingram P; Benítez-Peñuela MÁ; Rodríguez JY; Desoubeaux G; Barać A; García-Vidal C; Hoenigl M; Mehta SR; Cheng MP; Klyasova G; Heinz WJ; Iqbal N; Krause R; Ostermann H; Penack O; Schalk E; Sheppard DC; Willinger B; Wisplinghoff H; Vehreschild JJ; Cornely OA; Vehreschild MJGT;
J Antimicrob Chemother; 2019 Nov; 74(11):3315-3327. PubMed ID: 31393591
[TBL] [Abstract][Full Text] [Related]
3. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis.
Mihara T; Kakeya H; Izumikawa K; Obata Y; Nishino T; Takazono T; Kosai K; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Tsukamoto M; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S
J Infect Chemother; 2014 Feb; 20(2):104-8. PubMed ID: 24462443
[TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B treatment for rhinocerebral mucormycosis: how much is enough?
Handzel O; Landau Z; Halperin D
Rhinology; 2003 Sep; 41(3):184-6. PubMed ID: 14579660
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R;
Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465
[TBL] [Abstract][Full Text] [Related]
7. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study.
Arrieta AC; Shea K; Dhar V; Cleary JP; Kukreja S; Morris M; Vargas-Shiraishi OM; Ashouri N; Singh J
Clin Ther; 2010 Feb; 32(2):265-71. PubMed ID: 20206784
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B.
Saedi B; Sadeghi M; Seilani P
J Laryngol Otol; 2011 Aug; 125(8):807-10. PubMed ID: 21729440
[TBL] [Abstract][Full Text] [Related]
9. Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.
Azoulay E; Timsit JF; Lautrette A; Legriel S; Max A; Ruckly S; Misset B; Cohen Y; Wolff M
PLoS One; 2017; 12(5):e0177093. PubMed ID: 28531175
[TBL] [Abstract][Full Text] [Related]
10. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.
Abboud CS; Bergamasco MD; Baía CE; Lallée MP; Zan AS; Zamorano MM; Pereira OI; Mies S
Transplant Proc; 2012 Oct; 44(8):2501-2. PubMed ID: 23026630
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective investigation on the cases treated with liposomal amphotericin B].
Yamagishi Y; Mikamo H
Jpn J Antibiot; 2010 Oct; 63(5):347-64. PubMed ID: 21268407
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
14. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
Rieger CT; Dittmer M; Ostermann H
Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
[TBL] [Abstract][Full Text] [Related]
15. Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).
Caillot D; Thiébaut A; Herbrecht R; de Botton S; Pigneux A; Bernard F; Larché J; Monchecourt F; Alfandari S; Mahi L
Cancer; 2007 Dec; 110(12):2740-6. PubMed ID: 17941026
[TBL] [Abstract][Full Text] [Related]
16. Safe and successful endoarterial infusion of liposomal amphotericin B in treatment of mucormycosis.
Mansueto P; Rizzo M; Affronti M; Malta R; Carmina E; Mansueto S; Masellis M; Rini GB
New Microbiol; 2003 Oct; 26(4):395-8. PubMed ID: 14596351
[TBL] [Abstract][Full Text] [Related]
17. Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection.
Bodhe PV; Kotwani RN; Kirodian BG; Kshirsagar NA; Pandya SK
J Assoc Physicians India; 2002 May; 50(5):662-70. PubMed ID: 12186120
[TBL] [Abstract][Full Text] [Related]
18. Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: Efficacy and cost effectiveness in real-life.
Chong GL; Broekman F; Polinder S; Doorduijn JK; Lugtenburg PJ; Verbon A; Cornelissen JJ; Rijnders BJ
Int J Antimicrob Agents; 2015 Jul; 46(1):82-7. PubMed ID: 25956843
[TBL] [Abstract][Full Text] [Related]
19. Pediatric invasive mucormycosis cured with high dose liposomal amphotericin B.
Erbey F; Kocabaş E; Bayram İ; Soyupak S; Gümürdülü D; Tanyeli A
Tuberk Toraks; 2012; 60(4):375-9. PubMed ID: 23289469
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
Cornely OA; Marty FM; Stucker F; Pappas PG; Ullmann AJ
Mycoses; 2011 Nov; 54(6):e838-47. PubMed ID: 21668522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
